Karen Christman | |
---|---|
Born | Karen Leigh Christman |
Alma mater |
Northwestern University University of California, San Francisco |
Scientific career | |
Institutions |
University of California, San Diego University of California, Los Angeles |
Thesis | In situ engineered myocardial tissue (2003) |
Academic advisors | Heather Maynard |
Website |
christman |
Karen Leigh Christman is an American bioengineer who is the Associate Dean for Faculty Affairs and the Pierre Galletti Endowed Chair for Bioengineering Innovation at University of California, San Diego. [1] [2] Her research considers regenerative medicine and tissue engineering. She was elected a Fellow of the National Academy of Inventors in 2023.
Christman studied biomedical engineering at Northwestern University. She moved to California in 2000, where she earned her graduate degrees.[ citation needed] Christman was a doctoral researcher at the University of California, San Francisco (USCF), where she developed in situ approaches for myocardial tissue engineering. [3] She has said that she started working in biengineering to find a way to help patients. [4]
After her PhD, she moved to the University of California, Los Angeles for postdoctoral research, working with Heather Maynard on polymer chemistry to develop new strategies for site-specific patterning of proteins. [5] In 2007, Christman joined the Department of Bioengineering at UCSF. She develops materials for tissue engineering and regenerative medicine. Her research considers naturally-occurring and synthetically derived hydrogels to repair and regenerate tissue. [4] She looks to use these hydrogels for non-invasive therapeutic interventions. [4] In particular, Christman has studied myocardial infarction, which is a leading cause of death worldwide and from which many people do not recover full function. [4]
In 2017, Christman was one of the most highly funded researchers at UCSF, receiving a large grant from the California Institute for Regenerative Medicine to study peripheral artery disease. [6] She is the founder of Ventrix, Inc, [7] [8] which looks to create a new class of biotherapeutics that help the extracellular matrix guide the body to generate healthy tissue. [9]
Christman serves as editor-in-chief of NPG Regenerative Medicine. [10]
Her publications [1] [2] include:
Karen Christman | |
---|---|
Born | Karen Leigh Christman |
Alma mater |
Northwestern University University of California, San Francisco |
Scientific career | |
Institutions |
University of California, San Diego University of California, Los Angeles |
Thesis | In situ engineered myocardial tissue (2003) |
Academic advisors | Heather Maynard |
Website |
christman |
Karen Leigh Christman is an American bioengineer who is the Associate Dean for Faculty Affairs and the Pierre Galletti Endowed Chair for Bioengineering Innovation at University of California, San Diego. [1] [2] Her research considers regenerative medicine and tissue engineering. She was elected a Fellow of the National Academy of Inventors in 2023.
Christman studied biomedical engineering at Northwestern University. She moved to California in 2000, where she earned her graduate degrees.[ citation needed] Christman was a doctoral researcher at the University of California, San Francisco (USCF), where she developed in situ approaches for myocardial tissue engineering. [3] She has said that she started working in biengineering to find a way to help patients. [4]
After her PhD, she moved to the University of California, Los Angeles for postdoctoral research, working with Heather Maynard on polymer chemistry to develop new strategies for site-specific patterning of proteins. [5] In 2007, Christman joined the Department of Bioengineering at UCSF. She develops materials for tissue engineering and regenerative medicine. Her research considers naturally-occurring and synthetically derived hydrogels to repair and regenerate tissue. [4] She looks to use these hydrogels for non-invasive therapeutic interventions. [4] In particular, Christman has studied myocardial infarction, which is a leading cause of death worldwide and from which many people do not recover full function. [4]
In 2017, Christman was one of the most highly funded researchers at UCSF, receiving a large grant from the California Institute for Regenerative Medicine to study peripheral artery disease. [6] She is the founder of Ventrix, Inc, [7] [8] which looks to create a new class of biotherapeutics that help the extracellular matrix guide the body to generate healthy tissue. [9]
Christman serves as editor-in-chief of NPG Regenerative Medicine. [10]
Her publications [1] [2] include: